Header Logo

David Cimbaluk

Concepts (151)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Diseases
3
2019
109
0.590
Why?
Kidney Neoplasms
3
2015
79
0.540
Why?
Podocytes
4
2023
42
0.530
Why?
Carcinoma, Renal Cell
2
2015
48
0.450
Why?
Biopsy, Fine-Needle
7
2013
61
0.430
Why?
Glomerulonephritis, IGA
1
2011
9
0.380
Why?
Carcinoma, Papillary
1
2010
21
0.350
Why?
Lymphatic Metastasis
3
2010
90
0.350
Why?
Tumor Virus Infections
1
2009
16
0.330
Why?
Polyomavirus Infections
1
2009
26
0.330
Why?
Carcinosarcoma
1
2006
3
0.280
Why?
Uterine Neoplasms
1
2006
10
0.270
Why?
Adenoma
2
2021
60
0.270
Why?
Pleural Neoplasms
1
2006
11
0.260
Why?
Mesothelioma
1
2006
14
0.260
Why?
Enterocolitis
1
2005
3
0.250
Why?
Liver Neoplasms
2
2011
105
0.250
Why?
Candidiasis
1
2005
22
0.250
Why?
Carcinoma, Lobular
1
2005
21
0.250
Why?
Carcinoma, Ductal, Breast
1
2005
34
0.250
Why?
Immunocompromised Host
1
2005
46
0.250
Why?
Colonoscopy
2
2021
73
0.230
Why?
Cerebral Hemorrhage
1
2005
108
0.230
Why?
Humans
23
2023
28408
0.220
Why?
Receptors, Urokinase Plasminogen Activator
2
2023
22
0.210
Why?
Breast Neoplasms
2
2015
409
0.210
Why?
Proteinuria
2
2023
58
0.210
Why?
Neoplasms, Multiple Primary
2
2015
42
0.210
Why?
Coloring Agents
1
2021
14
0.190
Why?
Antibodies
1
2021
49
0.180
Why?
Mice
6
2023
1461
0.180
Why?
Female
12
2019
15708
0.170
Why?
Paraproteinemias
1
2019
6
0.160
Why?
Inducible T-Cell Co-Stimulator Ligand
1
2019
6
0.160
Why?
Integrin alphaVbeta3
1
2019
16
0.160
Why?
Middle Aged
9
2015
9254
0.150
Why?
Animals
6
2023
3780
0.140
Why?
Adult
5
2015
8097
0.140
Why?
CD11b Antigen
1
2017
15
0.140
Why?
Toll-Like Receptors
1
2017
17
0.140
Why?
Kidney Failure, Chronic
1
2019
165
0.140
Why?
Receptor, ErbB-4
1
2016
2
0.140
Why?
Receptor, Notch1
1
2016
6
0.140
Why?
Diabetes Mellitus, Experimental
1
2016
19
0.140
Why?
Diabetic Nephropathies
1
2016
22
0.140
Why?
Macrophages
1
2017
108
0.130
Why?
MicroRNAs
1
2016
54
0.130
Why?
Receptor, ErbB-2
2
2006
50
0.130
Why?
Up-Regulation
1
2016
177
0.130
Why?
Granulomatous Mastitis
1
2015
3
0.120
Why?
Angiomyolipoma
1
2015
3
0.120
Why?
Biopsy
3
2021
220
0.120
Why?
Lupus Erythematosus, Systemic
1
2017
192
0.110
Why?
Retrospective Studies
5
2019
3609
0.110
Why?
Lung Neoplasms
3
2011
553
0.110
Why?
Male
7
2017
15273
0.110
Why?
Wilms Tumor
1
2013
10
0.110
Why?
Urologic Neoplasms
1
2011
4
0.090
Why?
Carcinoma, Transitional Cell
1
2011
17
0.090
Why?
Rhabdomyosarcoma
1
2010
7
0.090
Why?
Trisomy
1
2010
3
0.090
Why?
Chromosomes, Human, Pair 17
1
2010
7
0.090
Why?
Bone Neoplasms
2
2011
120
0.090
Why?
DNA, Neoplasm
1
2010
20
0.090
Why?
In Situ Hybridization, Fluorescence
1
2010
34
0.090
Why?
Cytodiagnosis
2
2010
18
0.090
Why?
Nephrectomy
1
2010
40
0.090
Why?
Disease-Free Survival
1
2010
177
0.080
Why?
Soft Tissue Neoplasms
1
2010
54
0.080
Why?
BK Virus
1
2009
12
0.080
Why?
Adenocarcinoma
1
2011
147
0.080
Why?
Carcinoma, Squamous Cell
1
2011
177
0.080
Why?
Fatal Outcome
2
2006
57
0.080
Why?
Chondroma
1
2008
5
0.080
Why?
Biomarkers, Tumor
1
2010
202
0.080
Why?
Kidney Transplantation
1
2009
133
0.070
Why?
Chondrocytes
1
2008
155
0.070
Why?
Tissue Array Analysis
1
2006
7
0.070
Why?
Reed-Sternberg Cells
1
2006
2
0.070
Why?
Proto-Oncogene Proteins c-kit
1
2006
14
0.070
Why?
Cyclooxygenase 2
1
2006
28
0.070
Why?
Bronchi
1
2006
12
0.070
Why?
Carcinoma, Large Cell
1
2006
12
0.070
Why?
Mice, Knockout
2
2019
316
0.070
Why?
Hodgkin Disease
1
2006
17
0.070
Why?
ErbB Receptors
1
2006
54
0.070
Why?
Vascular Endothelial Growth Factor A
1
2006
71
0.070
Why?
Arteriovenous Malformations
1
2006
3
0.060
Why?
Gastric Mucosa
1
2006
10
0.060
Why?
Stomach
1
2006
15
0.060
Why?
Arteries
1
2006
16
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
20
0.060
Why?
Receptors, Progesterone
1
2005
24
0.060
Why?
Immunohistochemistry
1
2006
362
0.060
Why?
Cadherins
1
2005
36
0.060
Why?
Signal Transduction
2
2019
447
0.060
Why?
Neoplasm Staging
1
2006
371
0.060
Why?
Receptors, Estrogen
1
2005
60
0.060
Why?
Aged
4
2015
9262
0.050
Why?
Integrins
1
2023
14
0.050
Why?
Aged, 80 and over
2
2015
4853
0.050
Why?
Tomography, X-Ray Computed
1
2005
730
0.050
Why?
Staining and Labeling
1
2021
16
0.050
Why?
Fluorescent Antibody Technique
1
2021
58
0.050
Why?
Treatment Outcome
1
2010
3615
0.050
Why?
Observer Variation
1
2021
102
0.040
Why?
Diagnosis, Differential
2
2013
372
0.040
Why?
Receptor, PAR-2
1
2019
3
0.040
Why?
Protein Domains
1
2019
7
0.040
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
2
0.040
Why?
Amino Acid Motifs
1
2019
18
0.040
Why?
Protein Multimerization
1
2019
18
0.040
Why?
Adipocytes
1
2019
21
0.040
Why?
Kidney Function Tests
1
2019
22
0.040
Why?
Protein Isoforms
1
2019
48
0.040
Why?
Microscopy, Electron
1
2019
67
0.040
Why?
Immunoglobulin A
1
2019
13
0.040
Why?
Symptom Assessment
1
2019
20
0.040
Why?
HEK293 Cells
1
2019
67
0.040
Why?
Mice, Inbred BALB C
1
2019
106
0.040
Why?
Glomerular Filtration Rate
1
2019
53
0.040
Why?
Reproducibility of Results
1
2021
735
0.040
Why?
Mice, Transgenic
1
2019
225
0.040
Why?
Combined Modality Therapy
1
2019
307
0.040
Why?
Disease Management
1
2019
114
0.040
Why?
Mice, Inbred MRL lpr
1
2017
2
0.040
Why?
Interferon Regulatory Factor-3
1
2017
2
0.040
Why?
Forkhead Box Protein O3
1
2017
5
0.040
Why?
Interferon Regulatory Factor-7
1
2017
4
0.040
Why?
Interferon Type I
1
2017
11
0.030
Why?
Ribonucleases
1
2016
8
0.030
Why?
Erlotinib Hydrochloride
1
2016
11
0.030
Why?
Transforming Growth Factor beta1
1
2016
19
0.030
Why?
Chemokine CCL2
1
2016
19
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2017
50
0.030
Why?
Disease Models, Animal
1
2019
619
0.030
Why?
Polymorphism, Single Nucleotide
1
2017
284
0.030
Why?
Biomarkers
1
2019
596
0.030
Why?
Ultrasonography, Mammary
1
2015
10
0.030
Why?
Tuberous Sclerosis
1
2015
15
0.030
Why?
Severity of Illness Index
1
2019
986
0.030
Why?
Mammography
1
2015
48
0.030
Why?
Incidence
1
2015
773
0.020
Why?
Adrenal Gland Neoplasms
1
2011
11
0.020
Why?
Radiography
1
2013
639
0.020
Why?
Risk Factors
1
2016
2408
0.020
Why?
Chondroblastoma
1
2008
2
0.020
Why?
Histocytological Preparation Techniques
1
2008
3
0.020
Why?
Fibroma
1
2008
5
0.020
Why?
Chondrosarcoma
1
2008
33
0.020
Why?
Adolescent
1
2006
2307
0.010
Why?
Cimbaluk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (151)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_